Clik here to view.
7 medtech stories we missed: Feb. 10, 2017
[Image courtesy unsplash.com]From Glytec partnering to beat diabetes to Biolase, Gramercy Extremity Orthopedics and more getting FDA clearances, here are 7 recent medtech stories we missed this week,...
View ArticleClik here to view.
Despite stock backlash, reverse split moves Sunshine Heart back into NASDAQ’s...
Sunshine Heart (NSDQ:SSH) said today that NASDAQ gave official word that the company was complying with its $1 minimum bid price requirement. The news comes after the Eden Prairie, Minn.-based company...
View ArticleClik here to view.
Getinge inks distro deal for Ultra Clean Systems’ ultrasonic surgical...
Getinge (PINK:GETI B) said today it inked an exclusive distribution agreement with Ultra Clean Systems to distribute its ultrasonic surgical instrument cleaning systems. Through the deal, Getinge will...
View ArticleClik here to view.
Appeals court upholds Greabatch win over AVX
The US Court of Appeals for the Federal Circuit this week affirmed a Patent Trial and Appeal Board ruling granting $37.5 million in damages to Greatbatch, now known as Integer Holdings (NYSE:INTGR), in...
View ArticleClik here to view.
Retractable Technologies seeks Supreme Court review of BD decision
Retractable Technologies (NYSE:RVP) said today it filed a petition for a write of certiorari with the US Supreme Court to review an overturned its $352 million anti-trust win over Becton Dickinson...
View ArticleClik here to view.
Medtronic debuts outcomes training program for EMEA
Medtronic (NYSE:MDT) said today that it’s launching a outcomes-based training program in Europe, the Middle East & Africa that aims to reach 500,000 healthcare providers over the next 5 years. It’s...
View ArticleClik here to view.
Chinese FDA updates recall process for medical devices
By Stewart Eisenhart, Emergo Group Medical device regulators at the China Food and Drug Administration (CFDA) have issued a new provision on its recall process for defective devices. Get the full story...
View ArticleClik here to view.
Marathon hikes MD drug price 70x to $89k a year
After winning FDA approval for its muscular dystrophy drug last week, Marathon Pharmaceuticals set the drug’s list price at $89,000 a year – 50 to 70 times greater than what most U.S. patients have...
View ArticleClik here to view.
Allergan acquires Zeltiq Aesthetics in $2.48B deal
Allergan (NYSE:AGN) said today that it will pay $2.48 billion for Zeltiq Aesthetics Inc. (NSDQ:ZLTQ) and its portfolio of body-contouring products. Zeltiq’s FDA-approved CoolSculpting system uses a...
View ArticleClik here to view.
HeartFlow wins nod from U.K. healthcare board
The U.K.’s National Institute for Health & Care Excellence issued final guidance on HeartFlow‘s FFRct technology, which uses algorithms to generate 3D models of blood flows and can help diagnose...
View ArticleClik here to view.
AcelRx touts Dsuvia data for burn victims
AcelRx Pharmaceuticals (NSDQ:ACRX) said today that it plans to present data from a study evaluating its Dsuvia pain reliever in patients with moderate-to-severe acute pain resulting from trauma or...
View ArticleClik here to view.
Medtronic launches DxTerity, TRA-line of radial access devices for PCIs
Medtronic (NYSE:MDT) today announced a slew of new percutaneous coronary intervention devices it added to its portfolio, including the DxTerity diagnostic angiography catheter line, the DxTerity TRA,...
View ArticleClik here to view.
Pump makes breath biopsy more than a pipe dream
A micropump from TTP Ventus is enabling such innovations as Owlstone Medical‘ s breath biopsy technology, which is designed to detect early lung or bowel cancers through volatile organic compounds...
View ArticleClik here to view.
Teva Pharmaceutical beats Q4 earnings, sales estimates
Shares in Teva Pharmaceutical (NYSE:TEVA) rose today after the pharmaceutical company met expectations on Wall Street with its 4th quarter results. The Israel-based company posted a loss of -$974...
View ArticleClik here to view.
Intact Vascular launches BTK balloon angioplasty trial of its Tack...
Intact Vascular said today it launched the Toba II BTK clinical trial to evaluate the safety and efficacy of its Tack endovascular system along with standard balloon angioplasty for treating critical...
View ArticleClik here to view.
Researchers develop luminesent carbon nanodots to track drug delivery
Researchers from the University of Illinois at Urbana-Champaign have developed photo-luminescent carbon nanodots that exhibit reversible switching of their optical properties in cancer cells. The...
View ArticleClik here to view.
Siemens mulls US IPO for healthcare biz
Siemens (NYSE:SI) is mulling the idea of a US initial public offering for its Healthineers healthcare business, according to a German newspaper which spoke to its chief exec. The healthcare business,...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for February 12, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Report: Private equity shop Apax Partners in the hunt for Syneron
Private equity fund Apax Partners is reportedly looking to pick up aesthetic device maker Syneron Medical (NSDQ:ELOS) for between $350 and $400 million. Apax representatives met with Israel-based...
View ArticleClik here to view.
This brain-sensing headband gives scientists an idea of how brains age
A wireless brain-sensing headband is benefiting more than just the consumer. The valuable data that the headband creates and collects is shedding new light for neuroscience researchers on what happens...
View Article
